US Stock MarketDetailed Quotes
RNAC Cartesian Therapeutics
- 36.000
- +1.280+3.69%
Close Jun 3 16:00 ET
- 36.410
- +0.410+1.14%
Post 18:20 ET
640.66MMarket Cap-642P/E (TTM)
38.777High34.150Low146.77KVolume35.070Open34.720Pre Close5.37MTurnover4.09%Turnover RatioLossP/E (Static)17.80MShares38.77752wk High-5.49P/B129.07MFloat Cap11.66552wk Low--Dividend TTM3.59MShs Float728.003Historical High--Div YieldTTM13.33%Amplitude11.665Historical Low36.589Avg Price1Lot Size
Cartesian Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Jun 3, 2024
The average Cartesian Therapeutics stock price target is 43.50 with a max estimate of 54.00 and a min estimate of 38.00
Review Cartesian Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Jun 3, 2024
Heat List
US
Overall
Symbol
Latest Price
%Chg
